HSBC Holdings’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-32,177
Closed -$4.79M 2800
2019
Q4
$4.79M Sell
32,177
-2,090
-6% -$287K 0.01% 1118
2019
Q3
$4.24M Buy
34,267
+1,326
+4% +$177K 0.01% 1260
2019
Q2
$4.64M Sell
32,941
-157
-0.5% -$21.7K 0.01% 1170
2019
Q1
$4.99M Sell
33,098
-38,706
-54% -$5.57M 0.01% 1117
2018
Q4
$8.92M Buy
71,804
+5,226
+8% +$715K 0.02% 876
2018
Q3
$10.6M Buy
+66,578
New +$10.1M 0.02% 840

Other funds holding FBT

HSBC Holdings's FBT Position: Q1 2020 in Review

HSBC Holdings sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2020, closing a stake of 32,177 shares — an estimated $4.79M sold.

HSBC Holdings first reported a position in FBT in Q3 2018 and held it in 6 quarters. The position peaked at $10.6M in Q3 2018. 199 funds tracked by Wall St. Rank hold FBT as of Q1 2020.

  • HSBC Holdings reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2020 after selling out during the quarter.
  • HSBC Holdings sold 32,177 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2020, an estimated $4.79M.
  • HSBC Holdings first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2018 and held it in 6 quarters.
  • HSBC Holdings's First Trust NYSE Arca Biotechnology Index Fund position peaked at $10.6M in Q3 2018.
  • 199 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2020.

Based on HSBC Holdings's 13F filing for Q1 2020, filed 15 May 2020.